INTERNATIONAL PATENT: BIOTHEUS INC., BIONTECH SE FILES APPLICATION FOR "COMBINATION THERAPY COMPRISING A BISPECIFIC ANTI-VEGF-A AND ANTI-PD-L1 ANTIBODY AND A CHEMOTHERAPY FOR CANCER TREATMENT"

GENEVA, Sept. 15 -- BIOTHEUS INC. (10B, Building 4, No.1, Keji 7th Road, Tangjiawan TownZhuhai, Guangdong 519080), BIONTECH SE (An Der Goldgrube 12, 55131 Mainz) filed a patent application (PCT/CN2024/124994) for "COMBINATION THERAPY COMPRISING A BISPECIFIC ANTI-VEGF-A AND ANTI-PD-L1 ANTIBODY AND A CHEMOTHERAPY FOR CANCER TREATMENT" on Oct 15, 2024. With publication no. WO/2025/185161, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HU, Guoqiang (10B, Building 4, No.1, Keji 7th Road, Tangjiawan TownZhuhai, Guangdong 51908...